Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Cash from Investing Activities (2020 - 2025)

Maxcyte (MXCT) has disclosed Cash from Investing Activities for 6 consecutive years, with $9.7 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 681.14% to $9.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.9 million through Dec 2025, up 274.13% year-over-year, with the annual reading at $25.9 million for FY2025, 274.13% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was $9.7 million at Maxcyte, up from $5.2 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $194.8 million in Q1 2022, with the low at -$162.3 million in Q3 2021.
  • Average Cash from Investing Activities over 5 years is -$6.6 million, with a median of $2.2 million recorded in 2023.
  • The sharpest move saw Cash from Investing Activities plummeted 2939.61% in 2021, then soared 1141.41% in 2022.
  • Over 5 years, Cash from Investing Activities stood at -$11.4 million in 2021, then crashed by 136.88% to -$27.1 million in 2022, then skyrocketed by 84.72% to -$4.1 million in 2023, then soared by 59.77% to -$1.7 million in 2024, then surged by 681.14% to $9.7 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $9.7 million, $5.2 million, and $1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.